A business in context
CYTK research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-28 | Blum Robert I | M · Exercise / conversion | Common Stock | 7500.0 | 10.6 |
| 2026-09-28 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 65.46 |
| 2026-09-28 | Blum Robert I | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 7500.0 | 0.0 |
| 2026-09-22 | Malik Fady Ibraham | M · Exercise / conversion | Common Stock | 3500.0 | 7.8 |
| 2026-09-22 | Malik Fady Ibraham | S · Sale | Common Stock | 3500.0 | 68.29 |
| 2026-09-22 | Malik Fady Ibraham | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 3500.0 | 0.0 |
| 2026-09-15 | Landry Robert E | S · Sale | Common Stock | 1000.0 | 72.13 |
| 2026-09-15 | Blum Robert I | S · Sale | Common Stock | 97926.0 | 69.33 |
| 2026-09-14 | Blum Robert I | M · Exercise / conversion | Common Stock | 7500.0 | 10.6 |
| 2026-09-14 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 73.44 |
| 2026-09-14 | Blum Robert I | G · Gift | Common Stock | 1350.0 | 0.0 |
| 2026-09-14 | Blum Robert I | G · Gift | Common Stock | 97926.0 | 0.0 |
| 2026-09-14 | Blum Robert I | G · Gift | Common Stock | 97926.0 | 0.0 |
| 2026-09-14 | Blum Robert I | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 7500.0 | 0.0 |
| 2026-09-11 | Landry Robert E | S · Sale | Common Stock | 1000.0 | 74.66 |
| 2026-09-08 | Malik Fady Ibraham | M · Exercise / conversion | Common Stock | 3500.0 | 7.8 |
| 2026-09-08 | Malik Fady Ibraham | S · Sale | Common Stock | 3500.0 | 75.46 |
| 2026-09-08 | Malik Fady Ibraham | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 3500.0 | 0.0 |
| 2026-09-01 | PARSHALL B LYNNE | S · Sale | Common Stock | 5000.0 | 71.48 |
| 2026-08-31 | Callos Andrew | M · Exercise / conversion | Common Stock | 10000.0 | 23.26 |
| 2026-08-31 | Callos Andrew | S · Sale | Common Stock | 10000.0 | 70.24 |
| 2026-08-31 | Callos Andrew | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 10000.0 | 0.0 |
| 2026-08-31 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 70.24 |
| 2026-08-31 | Blum Robert I | M · Exercise / conversion | Common Stock | 7500.0 | 10.6 |
| 2026-08-31 | Blum Robert I | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 7500.0 | 0.0 |
| 2026-08-18 | Malik Fady Ibraham | M · Exercise / conversion | Common Stock | 3500.0 | 7.8 |
| 2026-08-18 | Malik Fady Ibraham | S · Sale | Common Stock | 3500.0 | 75.82 |
| 2026-08-18 | Malik Fady Ibraham | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 3500.0 | 0.0 |
| 2026-08-10 | Blum Robert I | M · Exercise / conversion | Common Stock | 7500.0 | 10.6 |
| 2026-08-10 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 76.76 |
| 2026-08-10 | Blum Robert I | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 7500.0 | 0.0 |
| 2026-07-30 | Callos Andrew | M · Exercise / conversion | Common Stock | 14000.0 | 23.26 |
| 2026-07-30 | Callos Andrew | S · Sale | Common Stock | 14000.0 | 79.88 |
| 2026-07-30 | Callos Andrew | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 14000.0 | 0.0 |
| 2026-07-27 | Blum Robert I | M · Exercise / conversion | Common Stock | 7500.0 | 10.6 |
| 2026-07-27 | Blum Robert I | S · Sale | Common Stock | 7500.0 | 80.87 |
| 2026-07-27 | Blum Robert I | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 7500.0 | 0.0 |
| 2026-07-21 | Malik Fady Ibraham | M · Exercise / conversion | Common Stock | 3500.0 | 7.8 |
| 2026-07-21 | Malik Fady Ibraham | S · Sale | Common Stock | 3500.0 | 80.59 |
| 2026-07-21 | Malik Fady Ibraham | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 3500.0 | 0.0 |
| 2026-07-15 | Wysenski Nancy | A · Grant / award | Common Stock | 75.0 | 82.62 |
| 2026-07-15 | WIERENGA WENDELL | A · Grant / award | Common Stock | 75.0 | 82.62 |
| 2026-07-15 | Kaye Edward M. MD | A · Grant / award | Common Stock | 151.0 | 82.62 |
| 2026-07-15 | HENDERSON JOHN T | A · Grant / award | Common Stock | 272.0 | 82.62 |
| 2026-07-15 | Harrington Robert Arthur | A · Grant / award | Common Stock | 151.0 | 82.62 |
| 2026-07-15 | Daly James M | A · Grant / award | Common Stock | 151.0 | 82.62 |
| 2026-07-13 | Blum Robert I | S · Sale | Common Stock | 10.0 | 82.02 |
| 2026-07-13 | Blum Robert I | S · Sale | Common Stock | 7490.0 | 82.02 |
| 2026-07-13 | Blum Robert I | M · Exercise / conversion | Common Stock | 7490.0 | 10.6 |
| 2026-07-13 | Blum Robert I | M · Exercise / conversion | Non-Qualified Stock Option (Right to Buy) | 7490.0 | 0.0 |
Identity & relationships
SEC issuer · 0001061983CYTOKINETICS INC
Search names and former names
View Wikidata identity and references ↗
- Cytokinetics · alias · wikidata
- Cytokinetics (United States) · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $18.47M | $19.84M |
| 2023-12-31 | $7.53M | $8.33M |
| 2022-12-31 | $94.59M | $108.88M |
| 2021-12-31 | $70.43M | $87.56M |
| 2020-12-31 | $55.83M | $72.68M |
| 2019-12-31 | $26.87M | $35.41M |
| 2018-12-31 | $31.50M | $42.27M |
| 2017-12-31 | $13.37M | $18.38M |